SELECT * FROM `stock_list` where symbol='TMOF' AND exchange = 'WBO' limit 0,1 SELECT * FROM `stock_list` where symbol='TMOF' AND exchange = 'WBO' limit 0,1 SELECT * FROM `stock_list` WHERE `symbol` = "TMOF" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1
Thermo Fisher Scientific (WBO:TMOF) Market Cap
Thermo Fisher Scientific's quarterly market cap
increased
from Sep. 2023 (€185,652 Mil) to Dec. 2023 (€186,364 Mil) and
increased
from Dec. 2023 (€186,364 Mil) to Mar. 2024 (€202,996 Mil).
Thermo Fisher Scientific's annual market cap
declined
from Dec. 2021 (€231,060 Mil) to Dec. 2022 (€203,808 Mil) and
declined
from Dec. 2022 (€203,808 Mil) to Dec. 2023 (€186,364 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Thermo Fisher Scientific's Enterprise Value for Today is €229,062 Mil.
Thermo Fisher Scientific Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Thermo Fisher Scientific's Market Cap
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's Market Cap falls into.
Thermo Fisher Scientific Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Thermo Fisher Scientific's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (WBO:TMOF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Thermo Fisher Scientific Market Cap Related Terms
Thank you for viewing the detailed overview of Thermo Fisher Scientific's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Thermo Fisher Scientific (WBO:TMOF) Business Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WBO:TMOF has been successfully added to your 